Immuno-metabolic interfaces in cardiac disease and failure

Author:

Bertero Edoardo1ORCID,Dudek Jan1,Cochain Clement23ORCID,Delgobo Murilo34ORCID,Ramos Gustavo34ORCID,Gerull Brenda45ORCID,Higuchi Takahiro36,Vaeth Martin7ORCID,Zernecke Alma2,Frantz Stefan34,Hofmann Ulrich34,Maack Christoph14ORCID

Affiliation:

1. Department of Translational Research, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078 Würzburg, Germany

2. Institute of Experimental Biomedicine, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany

3. Comprehensive Heart Failure Center (CHFC), Am Schwarzenberg 15, 97078 Würzburg, Germany

4. Department of Internal Medicine I, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany

5. Department of Cardiovascular Genetics, Comprehensive Heart Failure Center (CHFC), University Hospital Würzburg, Am Schwarzenberg 15, 97078 Würzburg, Germany

6. Department of Nuclear Medicine, University Hospital Würzburg, Josef-Schneider-Straße 2, 97080 Würzburg, Germany

7. Institute of Systems Immunology, Julius-Maximilians University Würzburg, Versbacher Str. 9 97078 Würzburg, Germany

Abstract

Abstract The interplay between the cardiovascular system, metabolism, and inflammation plays a central role in the pathophysiology of a wide spectrum of cardiovascular diseases, including heart failure. Here, we provide an overview of the fundamental aspects of the interrelation between inflammation and metabolism, ranging from the role of metabolism in immune cell function to the processes how inflammation modulates systemic and cardiac metabolism. Furthermore, we discuss how disruption of this immuno-metabolic interface is involved in the development and progression of cardiovascular disease, with a special focus on heart failure. Finally, we present new technologies and therapeutic approaches that have recently emerged and hold promise for the future of cardiovascular medicine.

Funder

Federal Ministry of Education and Research for the Comprehensive Heart Failure Center (BMBF

German Research Foundation [Deutsche Forschungsgemeinschaft

Interdisciplinary Center for Clinical Research [Interdisziplinäres Zentrum für Klinische Forschung

University Hospital Würzburg

German Research Foundation (DFG; Ma

Barth Syndrome Foundation

German Research Foundation (DFG

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine,Physiology

Reference168 articles.

1. Prevalence and determinants of the precursor stages of heart failure: results from the population-based STAAB cohort study;Morbach;Eur J Prev Cardiol,2020

2. Pharmacotherapy according to treatment guidelines is associated with lower mortality in a community-based sample of patients with chronic heart failure: a prospective cohort study;Störk;Eur J Heart Fail,2008

3. Antiinflammatory therapy with canakinumab for atherosclerotic disease;Ridker;N Engl J Med,2017

4. Efficacy and safety of low-dose colchicine after myocardial infarction;Tardif;N Engl J Med,2019

5. Colchicine in patients with chronic coronary disease;Nidorf;N Engl J Med,2020

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3